ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

HEALEY ALS, a platform trial testing multiple potential treatments for amyotrophic lateral sclerosis, is amending its master ...

Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 62 , 1753–1757 (2004). Article CAS Google Scholar ...

As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...

One of the goals of Neuralink has been to help "restore full body movement" for individuals with spinal cord injuries, quadriplegia, or amyotrophic lateral sclerosis (ALS). "When a Neuralink is ...

The Food and Drug Administration (FDA) has not approved stem cell therapy for amyotrophic lateral sclerosis (ALS). However, people could participate in clinical trials involving this ALS treatment.

Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...

US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...

Neuralink is planning trials to determine if its brain chip implant can control an “investigational assistive robotic arm.” "This is an important first step towards restoring not only digital freedom, ...

Massachusetts-based Disarm is focused on treatments for diseases caused by axonal degeneration, such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis. Disarm has discovered novel ...

PRIME includes volunteers who have lost the use of their hands due to a cervical spinal cord injury or amyotrophic lateral sclerosis ... assistive robotic arm. Elon Musk, the owner of both ...